Home > Journals > Public health > summary
 
      Advanced search    Shopping cart    French version 
 
Latest books
Catalogue/Search
Collections
All journals
Medicine
Biology and research
Public health
Environnement, Risques & Santé
- Current issue
- Archives
- Subscribe
- Order an issue
- More information
Agronomy and biotech.
My account
Forgotten password?
Online account   activation
Subscribe
Licences IP
- Instructions for use
- Estimate request form
- Licence agreement
Order an issue
Pay-per-view articles
Newsletters
How can I publish?
Journals
Books
Help for advertisers
Foreign rights
Book sales agents



 

Texte intégral de l'article
 
Printable version

Endocrine disruption and human reproduction risk assessment: Today's scientific challenges and the stakes for tomorrow


Environnement, Risques & Santé. Volume 10, Number 6, 454-68, Novembre-Décembre 2011, Synthèse

Résumé   Article gratuit  

Author(s) : Nadia Quignot, Robert Barouki, Emmanuel Lemazurier

Summary : For many years, the issue of endocrine disruptors (ED) has persisted as an unresolved question for research, the public and regulatory bodies. As the mechanisms of action of ED are progressively elucidated, other issues have arisen, in connection with new challenges. The strategy of evaluation of these substances has been supported: i) by multidisciplinary research intended to characterise the targets and modes of action of ED\; ii) by the development of highly specific tools\; and iii) by the development of an appropriate regulatory framework. Despite promising technologies, assessment of ED toxicity still has inherent limitations. Thus, researchers seeking to optimise the characterisation of hazards are moving in new directions, with lower doses, mixtures of substances, targeted exposure windows and ever more predictive tools.

Keywords : endocrine disruptors, risk assessment, technology, toxic actions

 

About us - Contact us - Conditions of use - Secure payment
Latest news - Conferences
Copyright © 2007 John Libbey Eurotext - All rights reserved
[ Legal information - Powered by Dolomède ]